Global decrease of OTRs leads to vessel rarefaction. by Dan Hu (144171)

“…If the OTRs decrease too much, there can be a global degeneration of the vessel system.…”

A comparison of this research with relevant literature. by Ying Shi (115282)

Dose response curves (in percent mean consumption) to increasing concentrations of (A) IR3535, (B) picaridin, and (C) DEET. by Jillian L. Sanford (582153)

Decrease in host peptides after MV infection. by Ingrid M. M. Schellens (377152)

Compensatory NA mutations decrease NA activity. by Scott E. Hensley (236654)

Host population bottlenecks decrease microbiome diversity. by Michael Ørsted (5926028)

Quantitative determination of mRNA expression levels according to losartan treatment with or without TGF- β1 for 48 hours. by Jin A. Choi (559035)

Subjects:

Changes in glycometabolism, cytokines, oxidative stress markers, and inflammation marker between baseline and 24 weeks in patients receiving anagliptin. by Takeshi Onoue (8367606)

Subjects:

Study flowchart. by Takeshi Onoue (8367606)

Subjects:

Baseline characteristics of the study population. by Takeshi Onoue (8367606)

Subjects:

The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells by Jin A. Choi (559035)

Subjects:

Primary cultured human trabecular meshwork cell (TM) inoculated with human cytomegalovirus strain AD169. by Jin A. Choi (559035)

Subjects:

Changes in serum lipid profiles between baseline and 24 weeks. by Takeshi Onoue (8367606)

Subjects:

Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial by Takeshi Onoue (8367606)

Subjects:

Sequence for forward and reverse primer sets used for real-time PCR. by Jin A. Choi (559035)

Subjects:

Quantitative determination of mRNA expression levels according to CMV AD169 infection with or without TGF- β1 and/or losartan (0.1 μM) 48 hours post infection. by Jin A. Choi (559035)

Subjects:

PRISMA for a systematic review and meta-analysis flow chart for effectiveness of shared decision-making for glycaemic control among type 2 diabetes mellitus adult patients, 2024. by Edosa Tesfaye Geta (16541924)

Decision curve analysis of PIERS-ML model on day 0 (a), day 4 (b), day 8 (c), and day 13 (d). by Guiyou Yang (10259597)

Decision curve analysis on day 0 (a), day 4 (b), day 8 (c), and day 13 (d) (fullPIERS model). by Guiyou Yang (10259597)

On the apparent decrease in Olympic sprinter reaction times by Payam Mirshams Shahshahani (5459369)

“…The results for the 100 m and 110 m hurdle events show that minimum reaction times have systematically decreased between 2004 and 2016 for both sexes, with women showing a marked decrease since 2008 that eliminated the sex difference in 2012. …”